-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U/y0fC+fxidCXqsiMoOam7nu/2zzF1S1jr69xsBWeokxOtqqCk1WYho7wWGLErCW EavZdllnx6/6GasBCYx40g== 0001240017-04-000002.txt : 20041217 0001240017-04-000002.hdr.sgml : 20041217 20041217152315 ACCESSION NUMBER: 0001240017-04-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041215 FILED AS OF DATE: 20041217 DATE AS OF CHANGE: 20041217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LYNX THERAPEUTICS INC CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VASICEK THOMAS J CENTRAL INDEX KEY: 0001240017 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 041211265 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2004-12-15 0000913275 LYNX THERAPEUTICS INC LYNX 0001240017 VASICEK THOMAS J 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 0 1 0 0 VP, Business Development Employee Stock Option (right to buy) 3.90 2004-12-15 4 A 0 5000 3.90 A 2014-12-15 Common Stock 5000 5000 D Subject to the optionee's Continuous Service to the Company, twenty percent (20%) of the shares subject to this option shall vest on the first (1st) anniversary of the Vesting Commencement Date, with the remaining shares vesting in equal shares on a monthly basis over the next four (4) years; provided, however, all of the shares subject to this option shall vest in full on the date that is six (6) months following the First Closing Date (as defined in that certain Acquisition Agreement, dated as of September 28, 2004, by and between the Company and Solexa Limited). Thomas J. Vasicek 2004-12-16 -----END PRIVACY-ENHANCED MESSAGE-----